Bath & Body Works, Inc. (NYSE:BBWI) Shares Purchased by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd boosted its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 243.7% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 100,967 shares of the company's stock after purchasing an additional 71,592 shares during the quarter. Y Intercept Hong Kong Ltd's holdings in Bath & Body Works were worth $3,061,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. South Dakota Investment Council boosted its stake in Bath & Body Works by 0.9% in the 1st quarter. South Dakota Investment Council now owns 433,284 shares of the company's stock worth $13,137,000 after purchasing an additional 3,780 shares during the period. Segall Bryant & Hamill LLC bought a new position in Bath & Body Works in the 1st quarter worth approximately $10,883,000. Victory Capital Management Inc. boosted its stake in Bath & Body Works by 14,732.0% in the 1st quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company's stock worth $206,119,000 after purchasing an additional 6,752,274 shares during the period. Massachusetts Financial Services Co. MA raised its holdings in shares of Bath & Body Works by 48.0% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 211,120 shares of the company's stock worth $6,401,000 after acquiring an additional 68,515 shares in the last quarter. Finally, Securian Asset Management Inc. bought a new position in shares of Bath & Body Works during the 1st quarter valued at approximately $499,000. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Stock Performance

BBWI traded down $1.58 on Thursday, hitting $31.43. The company had a trading volume of 3,590,129 shares, compared to its average volume of 5,145,320. The stock has a fifty day moving average price of $30.11 and a 200-day moving average price of $32.19. Bath & Body Works, Inc. has a 12-month low of $24.94 and a 12-month high of $41.87. The stock has a market capitalization of $6.65 billion, a price-to-earnings ratio of 8.38, a P/E/G ratio of 1.11 and a beta of 1.72.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.02. The business had revenue of $1.40 billion during the quarter, compared to the consensus estimate of $1.42 billion. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%. The company's quarterly revenue was up 2.9% on a year-over-year basis. During the same quarter last year, the company earned $0.38 earnings per share. Analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 20th. Shareholders of record on Friday, June 6th were issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.55%. The ex-dividend date of this dividend was Friday, June 6th. Bath & Body Works's dividend payout ratio is presently 21.33%.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on BBWI. UBS Group boosted their price target on shares of Bath & Body Works from $32.00 to $36.00 and gave the stock a "neutral" rating in a research report on Tuesday, May 20th. Raymond James Financial reduced their price target on shares of Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating on the stock in a research report on Thursday, April 17th. Barclays reduced their price target on shares of Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating on the stock in a research report on Friday, May 30th. JPMorgan Chase & Co. boosted their price target on shares of Bath & Body Works from $41.00 to $43.00 and gave the stock an "overweight" rating in a research report on Monday, May 19th. Finally, Telsey Advisory Group restated an "outperform" rating and issued a $38.00 price target (down from $43.00) on shares of Bath & Body Works in a research report on Thursday, May 29th. Four equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, Bath & Body Works currently has a consensus rating of "Moderate Buy" and an average target price of $42.00.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.